Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Monso, R. Cabrera, A. Moya, A. Mira, M. Garcia, X. Pomares, J. M. Antó (Sabadell, Valencia, Barcelona, Spain). Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 200

Member's Comments

No comment yet.

Related content which might interest you: The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Gut microbiomes in chronic obstructive pulmonary disease Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 Distal airways bacterial colonization and inflammatory pattern in children with different chronic lung diseases: A bronchoscopic study Source: Annual Congress 2010 - Fibre-optic bronchoscopy and bronchoalveolar lavage in the treatment of paediatric respiratory diseases Year: 2010 History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD exacerbations Year: 2014 Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003 The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011 Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017 A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients Source: Eur Respir J 2007; 30: Suppl. 51, 177s Year: 2007 Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Genomic variability of haemophilus in patients with COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD Source: Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020 Year: 2020 The pulmonary microbiome and immunological activity in IPF patients. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic. Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017